Literature DB >> 12749860

Ratjadones inhibit nuclear export by blocking CRM1/exportin 1.

Mario Köster1, Søren Lykke-Andersen, Yasser A Elnakady, Klaus Gerth, Peter Washausen, Gerhard Höfle, Florenz Sasse, Jørgen Kjems, Hansjörg Hauser.   

Abstract

In addition to previously isolated ratjadone A we describe three new members of this family, ratjadones B, C, and D, from another strain of the myxobacterium Sorangium cellulosum. We have investigated the properties of these ratjadones with respect to their activity on mammalian cell lines. We found IC(50) values in the picomolar range and a significant increase in the size of nuclei. A further examination showed that they inhibit the export of the leucine-rich nuclear export signal (LR-NES) containing proteins in different cell lines. Ratjadones are able to inhibit the formation of the nuclear export complex composed of the CRM1, RanGTP, and the cargo protein, as shown by two different in vitro assays. Finally, the binding of ratjadone C to CRM1 was demonstrated. These ratjadone activities are in the same concentration range as described for the polyketide leptomycin B (LMB) from Streptomyces sp. Like LMB, it seems that the ratjadones covalently bind to CRM1, inhibit cargo protein binding via LR-NES, and thereby block nuclear export. Thus, the ratjadones represent a new class of natural compounds which inhibit proliferation in eukaryotes by blocking nuclear export.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749860     DOI: 10.1016/s0014-4827(03)00100-9

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  30 in total

1.  The anti-inflammatory prostaglandin 15-deoxy-delta(12,14)-PGJ2 inhibits CRM1-dependent nuclear protein export.

Authors:  Mark Hilliard; Cornelia Frohnert; Christiane Spillner; Simone Marcone; Annegret Nath; Tina Lampe; Desmond J Fitzgerald; Ralph H Kehlenbach
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Nuclear export is evolutionarily conserved in CVC paired-like homeobox proteins and influences protein stability, transcriptional activation, and extracellular secretion.

Authors:  Shirley K Knauer; Gert Carra; Roland H Stauber
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 3.  Controlling protein compartmentalization to overcome disease.

Authors:  James R Davis; Mudit Kakar; Carol S Lim
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

4.  Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export.

Authors:  Sten Strunze; Lloyd C Trotman; Karin Boucke; Urs F Greber
Journal:  Mol Biol Cell       Date:  2005-04-06       Impact factor: 4.138

5.  Oligodendroglial maturation is dependent on intracellular protein shuttling.

Authors:  Peter Göttle; Jennifer K Sabo; André Heinen; Gene Venables; Klintsy Torres; Nevena Tzekova; Carlos M Parras; David Kremer; Hans-Peter Hartung; Holly S Cate; Patrick Küry
Journal:  J Neurosci       Date:  2015-01-21       Impact factor: 6.167

6.  Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors.

Authors:  Ori Kalid; Dora Toledo Warshaviak; Sharon Shechter; Woody Sherman; Sharon Shacham
Journal:  J Comput Aided Mol Des       Date:  2012-09-30       Impact factor: 3.686

Review 7.  Nuclear export of proteins and drug resistance in cancer.

Authors:  Joel G Turner; Jana Dawson; Daniel M Sullivan
Journal:  Biochem Pharmacol       Date:  2011-12-20       Impact factor: 5.858

8.  Subcellular transport of EKLF and switch-on of murine adult beta maj globin gene transcription.

Authors:  Yu-Chiau Shyu; Tung-Liang Lee; Shau-Ching Wen; Hsin Chen; Wei-Yuan Hsiao; Xin Chen; JauLang Hwang; Che-Kun James Shen
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

9.  Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1.

Authors:  Qingxiang Sun; Yazmin P Carrasco; Youcai Hu; Xiaofeng Guo; Hamid Mirzaei; John Macmillan; Yuh Min Chook
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

10.  Human multiple myeloma cells are sensitized to topoisomerase II inhibitors by CRM1 inhibition.

Authors:  Joel G Turner; Douglas C Marchion; Jana L Dawson; Michael F Emmons; Lori A Hazlehurst; Peter Washausen; Daniel M Sullivan
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.